FDA
-
-
-
-
-
-
-
Abivax to Present Data on Obefazimod at Digestive Disease Week®
-
-
-
-
-
-
-
Abivax reports quality of life improvements in ulcerative colitis trial
-
-
-
-
-
-
-
Abivax to present obefazimod data at gastroenterology conference
-
-
-
-
-
-
-
Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis
-
-
-
-
-
-
-
Abivax (ABVX) Announces Board Changes
-
-
-
-
-
-
-
Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation
-
-
-
-
-
-
-
Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

